Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Active, Not Recruiting

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

NCT03218488

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Uniklinik Graz Graz, Austria
  • UCL Hopital Saint-Luc Brussels, Belgium
  • UZ Leuven Leuven, Belgium
  • CHU de Liège - Domaine Universitaire du Sart Tilman Liège, Belgium
View all 30 locations
View Trial Details
Active, Not Recruiting

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT04929210

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations
  • Arizona Arthritis and Rheumatology Research PLLC 1 Avondale, Arizona, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Chandler, Arizona, United States
  • Arizona Arthritis and Rheumatology Research PLLC Mesa, Arizona, United States
  • Arizona Arthritis Research, PLC. Phoenix, Arizona, United States
View all 240 locations
View Trial Details
Active, Not Recruiting

A Long-term Extension Study of Ustekinumab in Pediatric Participants

NCT05092269

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +19 more
Locations
  • Children's Center For Digestive Healthcare, Llc Atlanta, Georgia, United States
  • Mount Sinai New York, United States
  • Levine Childrens at Atrium Health Charlotte, North Carolina, United States
  • Pediatric Specialists Of Virginia Fairfax, Virginia, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

NCT05049798

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations
  • OMI Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Hospital J. M. Ramos Mejía Buenos Aires, Argentina
  • Hospital Cordoba Córdoba, Argentina
View all 155 locations
View Trial Details
Active, Not Recruiting

A Study of Guselkumab in Participants With Active Psoriatic Arthritis

NCT04882098

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +10 more
Locations
  • Rheumatology Associates Birmingham, Alabama, United States
  • Arizona Arthritis and Rheumatology Research PLLC Flagstaff, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates PC Glendale, Arizona, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Tucson, Arizona, United States
View all 280 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

NCT03451851

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California, San Diego San Diego, California, United States
  • Dermatologic Surgery Specialists Macon, Georgia, United States
  • Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's Hospital Chicago, Illinois, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

A Study of SPY072 in Rheumatic Disease

NCT07148414

Conditions
Ankylosis, Arthritis, Arthritis, Psoriatic, +24 more
Locations
  • Site 113 Avondale, Arizona, United States
  • Site 118 Tucson, Arizona, United States
  • Site 114 Chula Vista, California, United States
  • Site 111 Covina, California, United States
View all 64 locations
View Trial Details

Related conditions